We are live on ! Find out more
IMNN icon

Imunon
IMNN

18 hedge funds and large institutions have $286K invested in Imunon in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

20% more funds holding

Funds holding: 15 → 18 (+3)

9% more capital inflows, than outflows

Capital inflows: $87.5K | Capital outflows: $80.6K

0.07% more ownership

Funds ownership: 4.4% → 4.47% (+0.07%)

Holders
18
Holders Change
+3
Holders Change %
+20%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HRT Financial
HRT Financial
New York
+$26.7K
2
Virtu Financial
Virtu Financial
New York
+$24.2K
3
Two Sigma Securities
Two Sigma Securities
New York
+$12.9K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$11.3K
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.73K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$66.2K
2
Citadel Advisors
Citadel Advisors
Florida
-$14.3K
3
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$73
4
JP Morgan Chase
JP Morgan Chase
New York
-$11

IMNN Hedge Fund Activity: Q4 2023 in Review

18 of the 6,878 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2023, worth a combined $286K — down 29% from $403K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new IMNN positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $26.7K. The largest seller was Vanguard Group, cutting an estimated $66.2K.

  • 18 institutional investors held Imunon (IMNN) as of Q4 2023, up from 15 in Q3 2023.
  • Funds reported $286K of Imunon stock for Q4 2023, down 29% quarter-over-quarter.
  • 4 funds opened new Imunon positions in Q4 2023 and 1 closed out, a net change of +3 holders.
  • The largest Imunon buyer in Q4 2023 was HRT Financial, an estimated $26.7K added.
  • The largest Imunon seller in Q4 2023 was Vanguard Group, an estimated $66.2K sold.

Based on aggregated 13F filings for Q4 2023.